Whitehawk Therapeutics (WHWK) Other Non-Current Assets (2018 - 2025)
Historic Other Non-Current Assets for Whitehawk Therapeutics (WHWK) over the last 8 years, with Q3 2025 value amounting to $2.0 million.
- Whitehawk Therapeutics' Other Non-Current Assets rose 3049.5% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 3049.5%. This contributed to the annual value of $1.4 million for FY2024, which is 2502.68% down from last year.
- As of Q3 2025, Whitehawk Therapeutics' Other Non-Current Assets stood at $2.0 million, which was up 3049.5% from $2.1 million recorded in Q2 2025.
- Whitehawk Therapeutics' Other Non-Current Assets' 5-year high stood at $2.3 million during Q1 2022, with a 5-year trough of $20000.0 in Q1 2021.
- In the last 5 years, Whitehawk Therapeutics' Other Non-Current Assets had a median value of $2.0 million in 2023 and averaged $1.7 million.
- Its Other Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 1158500.0% in 2022, then crashed by 2502.68% in 2024.
- Over the past 5 years, Whitehawk Therapeutics' Other Non-Current Assets (Quarter) stood at $2.2 million in 2021, then decreased by 1.58% to $2.2 million in 2022, then decreased by 14.33% to $1.9 million in 2023, then fell by 25.03% to $1.4 million in 2024, then skyrocketed by 41.32% to $2.0 million in 2025.
- Its Other Non-Current Assets was $2.0 million in Q3 2025, compared to $2.1 million in Q2 2025 and $1.4 million in Q1 2025.